Overview

Role of Intralesional Combined Injection of Furosemide and Digoxin in Cutaneous Warts at Tertiary Care Hospital in Karachi.

Status:
ENROLLING_BY_INVITATION

Trial end date:
2025-09-30

Target enrollment:

Participant gender:

Summary

Identify the effects of combined intralesional furosemide 20mg/2ml and digoxin 0.5mg/2ml in cutaneous warts given weekly are rather safe and effective treatment for cutaneous warts, focusing on their effectiveness and safety, at a tertiary care hospital in Karachi, Pakistan.

Phase:

EARLY_PHASE1

Details

Lead Sponsor:

Jinnah Postgraduate Medical Centre

Treatments:

Digoxin
Furosemide